Navigation Links
BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
Date:6/12/2008

NEWARK, N.J., June 12 /PRNewswire/ -- BioNeutral announced today the results of tests utilizing its Ygiene(TM) formulation to kill anthrax spores on contact. This chemical technology is designed to be used by the military and first responders in conjunction with any suspected anthrax exposure. "The Ygiene(TM) formulation killed all anthrax spores exposed to the formulation in as little as 15 seconds," said Dr. Philip Tierno, the Principal Investigator on the project. Dr. Tierno is the Director of Clinical Microbiology and Diagnostic Immunology at Tisch Hospital, New York University Medical Center. "This is an extraordinary result given the heartiness and particular difficulty in eradicating anthrax spores. The test compared results with a 10% solution of chlorine bleach which required almost 100 times the contact time to achieve the same test result. I expect this chemical technology will be used in applications which will prove beneficial, even life-saving, in hospital and other healthcare settings."

Dr. Andy Kielbania, Chief Scientist for BioNeutral, said, "We are currently continuing our corrosive and stability testing. As demonstrated by these exceptional results our combinational technology platform allows us to develop formulations that can deliver active ingredients with exceptional speed and pinpoint efficacy."

Mr. Raj Pamani, a member of the Board of Directors, said, "We look forward to introducing this technology to the Department of Homeland Security, Department of Defense and the City and State's Task Force on Bioterrorism."

About BioNeutral Laboratories Corporation

BioNeutral was organized in 2003 to commercialize a novel combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. The formulations are "Green" and include natural and common ingredients which are found in baby products and the foods we eat. T
'/>"/>

SOURCE BioNeutral Laboratories Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Indevus Announces Management Changes
2. Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results
3. Cell Therapeutics, Inc. Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor
4. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
5. Veridex Announces Agreement to Acquire the Assets of Immunicon Corporation
6. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
7. Diffusion Pharmaceuticals Announces Addition of Mark T. Giles to its Board of Directors
8. Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)
9. Appature Announces onKey as an Innovative Platform for Creating Microsoft HealthVault-Compatible Applications
10. Premier Research Announces Completion of Management Buyout
11. ProMetic announces Octapharma publication of PRDTS prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... , April 23, 2015  Propanc Health Group ... company, focuses on the development of cancer treatments ... company lead product includes PRP, a patented formulation ... chymotrypsinogen, as well as the enzyme amylase designed ... developing a combination of anti-cancer agents working in ...
(Date:4/23/2015)... Delpor, Inc. (Delpor), a biotechnology company focused ... Patent and Trademark Office has issued 2 new patents ... US Pat. No. 8,986,727 was issued on March 24, ... for the sustained release of therapeutic agents. The ... (zero-order) release of large and small molecules for several ...
(Date:4/22/2015)... 22, 2015 /PRNewswire/ - BioAmber Inc. (NYSE and EURONEXT Paris:BIOA) today announced that ... 2015 on Thursday, May 7, 2015 after the close ... and conference call for 4.30 pm ET (1.30 pm ... audio of the conference call will be webcast over ... of the news media and the general public. To ...
(Date:4/22/2015)... Calif. , April 22, 2015 ... and analytics, announced today that it has opened ... its continued growth and expansion.  The common stock ... Act, Section 506(c), a law intended to encourage ... regulations.  Prior to 506(c), small businesses largely relied ...
Breaking Biology Technology:Early Stage BioTech offers Plenty of Risk; Propanc Health Group Analyst Brief Issued by BrokerBank Securities, Inc. 2Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 2Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 3BioAmber Announces Webcast of Fiscal First Quarter 2015 Financial Results 2Steep Hill Launches $5M Limited Stock Offering 2Steep Hill Launches $5M Limited Stock Offering 3
... Wis. - Lucigen Corp . and ... giving Lucigen exclusive worldwide rights to manufacture and sell ... , ,Under the agreement, Imaxio will retain the right ... applications, but Lucigen will provide the cells to commercial ...
... - It has yet to turn a profit, and it ... scope, but the decision by Madison research tool manufacturer NimbleGen ... to $75 million is the latest bit of evidence that the ... continues a pattern of growth and visibility for NimbleGen, which ...
... Alfalight , a manufacturer of high-power diode lasers, has ... million from the U.S. Army Research Laboratory . ... suitable for pumping high-power, fiber-laser systems, developed in conjunction ... commercial products. , ,Manoj Kanskar, vice president of research ...
Cached Biology Technology:Lucigen Corp. enters global licensing agreement 2IPO-bound NimbleGen traveling in fast company 2IPO-bound NimbleGen traveling in fast company 3IPO-bound NimbleGen traveling in fast company 4
(Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... for the 2015 New York Design Awards under the ... New York City Design Awards are part of a ... over 2,500 ratings from the marketplace, industry and judging ...
(Date:4/9/2015)... Calif. , April 9, 2015 Synaptics ... interface solutions, announced today that it will report financial ... Thursday, April 23, 2015, after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
(Date:4/2/2015)... , April 2, 2015 At its 2015 ... Lake City , the American College of Medical ... new directors to its Board.  Members of the ACMG ... and for forming and advancing its policies and programs. ... profession. "It,s an eventful time in medical ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... Dana-Farber Cancer Institute researchers have identified a molecular mechanism ... how consuming foods rich in saturated fats and trans-fatty ... and increases one's risk of heart disease and certain ... scientists led by Bruce Spiegelman, PhD, report that the ...
... patients with high-risk breast cancer treated with radical mastectomy ... to better survival outcomes with few long-term toxic effects, ... which appears in the January 19 issue of the ... Columbia randomized radiation therapy trial was designed to determine ...
... recent U.S. study, investigators in Japan found no association ... of high blood pressure, as reported in the March ... available online. , The researchers reported that they were ... known as the Kaposi's sarcoma virus, in the lungs ...
Cached Biology News:Scientists ID molecular 'switch' in liver that triggers harmful effects of saturated and trans fats 2Scientists ID molecular 'switch' in liver that triggers harmful effects of saturated and trans fats 3Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down 2Association of herpesvirus with lung disorder questioned 2
Yersinia pestis...
... The features we add to WinList come ... product every day. Features like automatic region ... the result of good suggestions, thoughtful conversations, ... the features you depend on are still ...
Insect Cell Lysis Buffer 50 ml...
Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....
Biology Products: